BMLL — Bio Medica Laboratories Balance Sheet
0.000.00%
- IN₹1.54bn
- IN₹1.69bn
- IN₹381.95m
Annual balance sheet for Bio Medica Laboratories, fiscal year end - March 31st, millions except per share.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ||
| Standards: | — | — | IAS | IAS | IAS |
| Status: | fx Preliminary | fx Preliminary | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | — | — | 0.061 | 0.103 | 0.068 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | — | 49.8 | 30.5 | 128 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | — | — | 91 | 106 | 311 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | — | 83.1 | 87.3 | 74.6 |
| Other Long Term Assets | |||||
| Total Assets | — | — | 176 | 195 | 391 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | — | — | 102 | 65.6 | 170 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | — | — | 151 | 146 | 244 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | — | — | 24.4 | 49.4 | 147 |
| Total Liabilities & Shareholders' Equity | — | — | 176 | 195 | 391 |
| Total Common Shares Outstanding |